Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells

Phospholipase D2 (PLD2) generates phosphatidic acid through hydrolysis of phosphatidylcholine. PLD2 has been shown to play a role in enhancing tumorigenesis. The epidermal growth factor receptor (EGFR) can both activate and interact with PLD2. Murine lymphoma EL4 cells lacking endogenous PLD2 presen...

Full description

Bibliographic Details
Main Authors: Manpreet S. Chahal, Daniel J. Brauner, Kathryn E. Meier
Format: Article
Language:English
Published: MDPI AG 2010-07-01
Series:Pharmaceuticals
Subjects:
Online Access:http://www.mdpi.com/1424-8247/3/7/2045/
_version_ 1818116285663281152
author Manpreet S. Chahal
Daniel J. Brauner
Kathryn E. Meier
author_facet Manpreet S. Chahal
Daniel J. Brauner
Kathryn E. Meier
author_sort Manpreet S. Chahal
collection DOAJ
description Phospholipase D2 (PLD2) generates phosphatidic acid through hydrolysis of phosphatidylcholine. PLD2 has been shown to play a role in enhancing tumorigenesis. The epidermal growth factor receptor (EGFR) can both activate and interact with PLD2. Murine lymphoma EL4 cells lacking endogenous PLD2 present a unique model to elucidate the role of PLD2 in signal transduction. In the current study, we investigated effects of PLD2 on EGF response. Western blotting and RT-PCR were used to establish that both parental cells and PLD2 transfectants express endogenous EGFR. Levels of EGFR protein are increased in cells expressing active PLD2, as compared to parental cells or cells expressing inactive PLD2. EGF stimulates proliferation of EL4 cells transfected with active PLD2, but not parental cells or cells transfected with inactive PLD2. EGF-mediated proliferation in cells expressing active PLD2 is dependent on the activities of both the EGFR and the PI3K/Akt pathway, as demonstrated by studies using protein kinase inhibitors. EGF-induced invasion through a synthetic extracellular matrix is enhanced in cells expressing active PLD2, as compared to parental cells or cells expressing inactive PLD2. Taken together, the data suggest that PLD2 acts in concert with EGFR to enhance mitogenesis and invasion in lymphoma cells.
first_indexed 2024-12-11T04:20:05Z
format Article
id doaj.art-cbe6c10eee7840c0940eb8a5961c48f2
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-12-11T04:20:05Z
publishDate 2010-07-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-cbe6c10eee7840c0940eb8a5961c48f22022-12-22T01:21:09ZengMDPI AGPharmaceuticals1424-82472010-07-01372045205810.3390/ph3072045Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma CellsManpreet S. ChahalDaniel J. BraunerKathryn E. MeierPhospholipase D2 (PLD2) generates phosphatidic acid through hydrolysis of phosphatidylcholine. PLD2 has been shown to play a role in enhancing tumorigenesis. The epidermal growth factor receptor (EGFR) can both activate and interact with PLD2. Murine lymphoma EL4 cells lacking endogenous PLD2 present a unique model to elucidate the role of PLD2 in signal transduction. In the current study, we investigated effects of PLD2 on EGF response. Western blotting and RT-PCR were used to establish that both parental cells and PLD2 transfectants express endogenous EGFR. Levels of EGFR protein are increased in cells expressing active PLD2, as compared to parental cells or cells expressing inactive PLD2. EGF stimulates proliferation of EL4 cells transfected with active PLD2, but not parental cells or cells transfected with inactive PLD2. EGF-mediated proliferation in cells expressing active PLD2 is dependent on the activities of both the EGFR and the PI3K/Akt pathway, as demonstrated by studies using protein kinase inhibitors. EGF-induced invasion through a synthetic extracellular matrix is enhanced in cells expressing active PLD2, as compared to parental cells or cells expressing inactive PLD2. Taken together, the data suggest that PLD2 acts in concert with EGFR to enhance mitogenesis and invasion in lymphoma cells.http://www.mdpi.com/1424-8247/3/7/2045/protein kinase inhibitorsphospholipids metabolismmetastasis
spellingShingle Manpreet S. Chahal
Daniel J. Brauner
Kathryn E. Meier
Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells
Pharmaceuticals
protein kinase inhibitors
phospholipids metabolism
metastasis
title Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells
title_full Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells
title_fullStr Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells
title_full_unstemmed Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells
title_short Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells
title_sort phospholipase d2 enhances epidermal growth factor induced akt activation in el4 lymphoma cells
topic protein kinase inhibitors
phospholipids metabolism
metastasis
url http://www.mdpi.com/1424-8247/3/7/2045/
work_keys_str_mv AT manpreetschahal phospholipased2enhancesepidermalgrowthfactorinducedaktactivationinel4lymphomacells
AT danieljbrauner phospholipased2enhancesepidermalgrowthfactorinducedaktactivationinel4lymphomacells
AT kathrynemeier phospholipased2enhancesepidermalgrowthfactorinducedaktactivationinel4lymphomacells